Lukas Jeker։ Making Genomic Medicine Affordable for More Patients
Lukas Jeker, Assistant Professor Experimental Transplantation Immunology and Nephrology at University Hospital Basel, shared a post on LinkedIn about a recent article by Fyodor Urnov and Sadik Kassim, published in Nature։
”Very thoughtful words from Fyodor Urnov and Sadik Kassim.
Time and costs to perform safety and efficacy testing are key obstacles that prevent more genome-editing therapies to benefit patients.
Fyodor and Sadik outline 4 key aspects that need to change to move faster, cut costs and scale.
I hope they are correct that costs can be cut dramatically and I hope successful deployment will convince other regulators to adopt similar regulatory frameworks.
Some of the article is US-centric but similar principles can be applied to other legislations.
Some principles will be universal (mainly scientific), others will need local adaptation, and maybe someone can further improve the approach?
Looking forward to what’s to come.
Thanks Fyodor and Sadik (and the many others who are pioneering such treatments) for your energy to bring change.
The last paragraph is particularly strong!
Read it (including the dollar COI disclosure).
I hope there will be a time when we look back and say: yes, there was a time when genomic medicine was unaffordable for most people.
Personalized CRISPR therapies could soon reach thousands – here’s how.”
Title: Personalized CRISPR therapies could soon reach thousands — here’s how
Authors: Fyodor D. Urnov, Sadik H. Kassim

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support